Discovery of <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFRSimon Planken, Jennifer Lafontaine, Louise Bernier et al.|Journal of Medicinal Chemistry|2017Cited by 90
Knockdown of METTL14 suppresses the malignant progression of non‑small cell lung cancer by reducing Twist expressionFang Yang, Yiqin Luo|Oncology Letters|2021Cited by 24
Dehydrogenase/reductase SDR family member�2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expressionJi‐Min Li, Yiqin Luo|Oncology Reports|2019Cited by 10
CCDC 1541947: Experimental Crystal Structure DeterminationSimon Planken, Jennifer Lafontaine, Douglas C. Behenna et al.|The Cambridge Structural Database|2017Cited by 0